Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1658-2026Class II

BD Kiestra" ReadA; Catalog No.: 446948

BD Kiestra B.V. / initiated 2026-02-06 / Open, Classified / root cause: software

BD KIESTRA LAB AUTOMATION began a recall of BD Kiestra" ReadA; Catalog No.: 446948 on . FDA classified it as Class II and gives the reason as "In certain situations, following a system reboot, one or more modules may have become unreachable via the remote connectivity interface. When this occurred, there was potential for delays in plate retrieval from the...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-1658-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
BD Kiestra B.V.
Product
BD Kiestra" ReadA; Catalog No.: 446948.
Product code
JTQ Bath, Incubators/Water, All
Reason for recall
In certain situations, following a system reboot, one or more modules may have become unreachable via the remote connectivity interface. When this occurred, there was potential for delays in plate retrieval from the incubator while connectivity was restored. This issue was intermittent and did not affect test results, performance of the assay, or sample integrity.
Root cause tag
software
FDA root cause
Software Manufacturing/Software Deployment
Action
On February 6, 2026 customers were contacted via phone call with a follow-up URGENT: Medical Device Correction letter were sent to customers on or about March 10, 2026. Actions to be taken: 1. Ensure the contents of this notification are read and understood. 2. Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 3. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification per FDA requirements. 4. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program via: Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088)
Quantity in commerce
82 units (7 US, 65 OUS)
Distribution
Domestic: KS, MD, MN, NJ, TX, VA; International: Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Hong Kong, Italy, Kuwait, Mexico, Morocco, Netherlands, Norway, Saudi Arabia, Spain, Sweden, Switzerland, Taiwan, United Kingdom;
Product codes and lots
Catalog No.: 446948; UDI-DI: 00382904469481; Serial Numbers: All;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1658-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1658-2026Class IIOngoingVoluntary: Firm initiated